OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹113 Cr | ₹109 Cr | ₹40 Cr | ₹31 Cr | ₹61 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹113 Cr |
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹61 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹113 Cr | 3.37 | |
| Mar2025 | ₹109 Cr | 175.72 | |
| Mar2024 | ₹40 Cr | 27.93 | |
| Mar2023 | ₹31 Cr | -48.80 | |
| Mar2022 | ₹61 Cr | - | |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹242.9 Cr | 33.9% | 33.9% | -44.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 33.9% |
33.9% |
-44.6% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses